Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Science

NNadir

(33,509 posts)

5. There is a very valid scientific reason for evaluating this drug in Covid.

Reply to secondwind (Reply #1)

Thu Apr 30, 2020, 10:14 AM

Apr 2020

Antivirals of this type have successfully done what was essentially impossible before the 1990's: Treat active viral diseases.

Gilead - irrespective of who owns them - successfully developed a drug (which they did not discover, although the discoverers became rich) that cures previously untreatable Hepatitis. Whether or not Donald Rumsfeld profited as a result does not mean that the drug didn't save lives.

Edit history

Please sign in to view edit histories.

18 replies

= new reply since forum marked as read

Highlight:

Clinical Improvement in Covid Remdesivir Double Blind Study Is Not Statistically Significant. [View all] NNadir Apr 2020 OP

I understand that Gilead has ties with Kushner.. That is all we need to know secondwind Apr 2020 #1

yeah, but then it means NJCher Apr 2020 #3

It most assuredly does NOT mean that. The study to which I referred did not rule out... NNadir Apr 2020 #11

so were you aware of what Fauci said when you wrote this post? NJCher Apr 2020 #13

I did not review exactly what he said, but heard it by osmosis. The news item leading to the... NNadir Apr 2020 #16

There is a very valid scientific reason for evaluating this drug in Covid. NNadir Apr 2020 #5

That was my first guess when I heard 15 days shortened to 11 days unblock Apr 2020 #2

Also a nice look over there moment for Trump when he's getting pummeled. gibraltar72 Apr 2020 #4

A few things. Igel Apr 2020 #14

On Remdesivir ... in 1,090 test cases it dropped the mortality rate from 11.6% to 8.0% Botany Apr 2020 #6

We'll see. The study to which I referred did not say the drug didn't have any effect... NNadir Apr 2020 #9

Time will tell. With more numbers treated, it may well reach statistical signficance hlthe2b Apr 2020 #7

after working in big pharma for 25 years, I looked at the data NRaleighLiberal Apr 2020 #8

And that is the reason, the FDA always assembles a committee of scientists to review the data. NNadir Apr 2020 #18

Note: STOPPED early because of adverse events 12% versus 5% in placebo. . . nt Bernardo de La Paz Apr 2020 #10

That's the impression I had as well reading this. drray23 Apr 2020 #12

Also, it appears that "adverse effects" were more than double in the Remdesivir group... Sancho Apr 2020 #15

Every drug has side effects. This one, since it acts on nucleic acid synthesis... NNadir Apr 2020 #17